Merck Will License Merck COVID-19 Pill Royalty-Free

Pfizer announced its new antiviral pill reduced risk of hospitalization or death from COVID-19 by 89 percent

Pharmaceutical company Merck & Co. has announced it will allow drugmakers around the world to produce its potentially lifesaving antiviral pill for treatment of COVID-19 without paying royalties as long as COVID-19 is considered a global health threat. Continue reading “Merck Will License Merck COVID-19 Pill Royalty-Free”